The agents, which are pharmacologically active on smooth muscle cells of the ureter, cause contraction or relaxation and change their spike generation though the exact mechanism is not clearly understood.
Theoretically, this course should govern an equivalent trend in the outcomes in both in vitro and in vivo experiments, but the actual findings have been conflicting with each other when many drugs are concerned.
The incongruity in the results may be due to the difference between experi mental conditions in vitro and in vivo. As far as in vitro studies are concerned, experimental conditions can he controlled consistently and the results are expected to be relatively congruous, but it is extremely difficult to control experimental conditions for in vivo studies; besides the inevitable limitation in techniques for recording ureteral activities in situ, there are many factors which affect the ureteral activity, such as temperature, blood flow, ph of urine, and the amount of urine excreted.
Among these factors, the change in the amount of urine flow seems the most difficult problem in pharmacological effects on ureteral peristalsis.
As has been noted in our previous report (Tsuchida 1969 ), ureteral peristalsis is markedly affected by the change in the amount of urine flow. Therefore, the drugs which affect renal function change urine flow, and as the result of change in urine flow, et al. norepinephrine and phenylephrine showed the effect on the electroureterograms of diminishing intervals of the action potential discharge (P<0.05), with the addi tional manifestations of the enlarged amplitude in norepinephrine and a slight prolongation in travel rates in epinephrine, though the latter was not tabulated statistically. Of 8 cases treated with isoproterenol, in 3 cases the action potential discharge stopped for 60-150 seconds, and in the other 5 cases a prominent prolon gation in discharge interval was observed (Fig. 4) . Phentolamine and propranolol showed no clear effect on ureteral activity. The epinephrine injection following the pre-administration of phentolamine had the immediate effect of a transient prolongation of a spike interval at P<0.005 and a transient fall in blood pressure for 5-10 seconds, though the latter was not quantitated statistically (Fig . 5) . Our in vivo experiments, unlike those in vitro, produced results which are not always compatible with other authors. Discrepancy in the results may partly be due to the differences in the methods for in situ use of drugs, species of animals used, and/or individual ureteral sensitivities of the drugs. Mainly, however, it may be caused by the change in the amount of urine flow due to the drug.
The effects of cholinergic stimulants studied in vitro have been reported with incongruous results by various workers. The effect of neostigmine affirmed by O'Conor (1939) to promote ureteral peristalsis was challenged by Chen et al. (1957) , and Kuwabara and Rikimaru (1969) . Also the effect of acetylcholine to increase peristaltic frequencies, confirmed by Gruber (1928) and Deane (1967) , was denied by Chen et al. (1957) and Borgstedt et al. (1962) . Shiratori et al. (1957) reported that in the in vivo study of neostigmine on electroureterograms, the acceleration of the ureteral activity was indiscernible with a small dose of this drug, but became evident with the increase in dose. In other experiments no effect of neostigmine was observed (Lapides 1948) . Acetylcholine examined in vitro tended to promote ureteral activity in the swine ureter in studies of Gruber (1928) and Dean (1967), but had no response in the canine ureter (Chen et al. 1957 ). This drug, in vivo, accelerated canine ureteral contraction frequencies in the studies of Sleator and Butcher (1955) using electroureterograms and of Kill and Kjekshus (1966) using the intraluminal tension recording technique. In our experiments, neostigmine had no effect but acetylcholine apparently accelerated ureteral activity. As for the effect of atropine on ureteral activity, suppression was noted by Satani (1919) , and a tendency toward acceleration in small doses and suppression in large doses was stated by Macht (1916) , while no effect was confirmed in the experiments of Chen et al. (1957) , or Kuwabara and Rikimaru (1969) . In experiments in vivo, we have confirmed no effect of atropine on ureteral activity in agreement with Lapides (1948) and Kill (1957). As stated above, the effects of cholinergic drugs on the ureteral function are inconsistent by various workers both in vitro and in vivo. As the result of a histochemical experiment for staining cholinesterase in the ureter, Kuwabara and Rikimaru (1969) stated that no positive reaction of specific cholinesterase activity indicated the possible absence of cholinergic nervous tissue in the ureteral musculature. From this result, it is presumed that the ureteral sensitivity to choline is extremely delicate in vivo.
No direct effect of DMPP on ureteral activity was noted by Kuwabara and Rikimaru (1969) in their in vitro experiments with the excised canine ureter, but in our experiments this ganglion stimulant accelerated ureteral peristalsis (P < 0.05). No distinct effect of hexamethonium on the ureteral activity has been found in our experience, in agreement with the common view of most authors.
The control of the ureteral activity of the autonomic nervous system has been argued variously by many authors. Engelmann (1869), Dogiel (1878) and Hryntschak (1925) the ganglia at the renal hilum, eventually producing changes in ureteral peristal sis. However, in another possible interpretation, DMPP might have stimulated the adrenal medulla and the other postganglionic adrenergic neuron causing catecholamine secretion. In fact, the blood pressure was increased by the injec tion of DMPP. On the other hand, in the experiments of Kill and Kjekshus (1966) concerning the serotonin effect on the ureteral function, it was suggested that the serotonin-induced acceleration of intestinal peristalsis might encourage the activity of ureteral peristalsis. This suggestion of the mechanical influence of accelerated intestinal peristalsis upon ureteral activity is plausible because in our experimental dogs the tendency to urinate increased following DMPP administration. Various problems, however, still remain to be settled before a final identification of the effect of DMPP upon ureteral peristalsis can be made.
